0001415889-24-003023.txt : 20240208
0001415889-24-003023.hdr.sgml : 20240208
20240208165221
ACCESSION NUMBER: 0001415889-24-003023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240207
FILED AS OF DATE: 20240208
DATE AS OF CHANGE: 20240208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ho William Tai-Wei
CENTRAL INDEX KEY: 0001830914
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39692
FILM NUMBER: 24609872
MAIL ADDRESS:
STREET 1: C/O IN8BIO, INC.
STREET 2: 79 MADISON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IN8BIO, INC.
CENTRAL INDEX KEY: 0001740279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 825462585
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: EMPIRE STATE BUILDING
STREET 2: 350 5TH AVENUE, SUITE 5330
CITY: NEW YORK
STATE: NY
ZIP: 10118
BUSINESS PHONE: (646) 600-6438
MAIL ADDRESS:
STREET 1: EMPIRE STATE BUILDING
STREET 2: 350 5TH AVENUE, SUITE 5330
CITY: NEW YORK
STATE: NY
ZIP: 10118
FORMER COMPANY:
FORMER CONFORMED NAME: Incysus Therapeutics, Inc.
DATE OF NAME CHANGE: 20180510
4
1
form4-02082024_090210.xml
X0508
4
2024-02-07
0001740279
IN8BIO, INC.
INAB
0001830914
Ho William Tai-Wei
C/O IN8BIO, INC.
350 5TH AVE. SUITE 5330
NEW YORK
NY
10118
true
true
true
false
PRESIDENT AND CEO
0
Employee Stock Option (right to buy)
1.22
2024-02-07
4
A
0
502000
0
A
2034-02-07
Common Stock
502000
502000
D
Twenty-five percent (25%) of the shares subject to the option shall vest on February 7, 2025 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
/s/ Jason Minio, Attorney-in-Fact
2024-02-08